Yoshida M, Origasa H, Seki N. Comparison of Silodosin versus Tadalafil in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. Low Urin Tract SymptomsLow Urin Tract Symptoms2017. 9, 176-186.
Yoshida M, Nozawa Y, Kato D, Tabuchi H.Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder Aged ≥75 Years: Analysis of a Japanese Post-Marketing Study. Low Urin Tract Symptoms. 2017. On line
Takeda M, Yokoyama O, Yoshida M, Nishizawa O, Hirata K, Nakaoka R, Takita Y, Murakami M. Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study.Int J Urol, Int J Urol. 2017; 24:539-547.
Majima T, Yamamoto T, Funahashi Y, Takai S, Matsukawa Y, Yoshida M, Gotoh M. Effect of Naftopidil on Bladder Microcirculation in a Rat Model of Bladder Outlet Obstruction.Low Urin Tract Symptoms 2017, 9, 111-116
Nishii H, Yoshida Y, Nakato K, Kanzaki Y, Hashimoto T, Kubo K, Fujimoto N, Matsumoto T, Nomiya M, Yoshida M.Successful preventive education of lower urinary tract dysfunction and promotion of independence in toileting skills for elderly citizens, a cooperative activity with urologists, physiotherapists, occupational therapists, nursing staffs, care staffs, non-profit organization staffs administered by local city government International Continence Society 2017
Nomiya M, Sawada N, Yoshida M, Yamaguchi O, Andersson KE.Protective effect of tadalafil on endothelial function of bladder microvessels in a rat model of chronic bladder ischemia International Continence Society 2017
Ogama N, Yoshida M, Nakai T, Niida S, Toba K and Sakurai T.Frontal white matter hyperintensity predicts lower urinary tract dysfunction in older adults with amnestic mild cognitive impairment and Alzheimer’s disease.Geriatr Gerontol Int, 2016.16(2):167-74
Takahashi S, Takei M, Nishizawa O, Yamaguchi O, Kato K, Gotoh M, Yoshimura Y, Takeyama M, Ozawa H, Shimada M, Yamanishi T, Yoshida M, Tomoe H, Yokoyama O, Koyama M Clinical Guideline for Female Lower Urinary Tract Symptoms.Low Urin Tract Symptoms. 2016.8(1):5-29
Goi Y, Tomiyama Y, Maruyama I, Tatemichi S, Maruyama K, Kobayashi M, Nomiya M, Yamaguchi O.Silodosin, an α(1A)-Adrenoceptor Antagonist, May Ameliorate Ischemia-Induced Bladder Denervation and Detrusor Dysfunction by Improving Bladder Blood Flow.Pharmacology. 2016;97(3-4):161-70.
Sawada N, Nomiya M, Zarifpour M, Mitsui T, Takeda M, Andersson KE.Melatonin Improves Erectile Function in Rats With Chronic Lower Body Ischemia.J Sex Med. 2016 Feb;13(2):179-86.
Miyazaki N, Yamaguchi O, Nomiya M, Aikawa K, Kimura J.Preventive Effect of Hydrogen Water on the Development of Detrusor Overactivity in a Rat Model of Bladder Outlet Obstruction.J Urol. 2016 Mar;195(3):780-7.
和文
著書
吉田正貴 薬物療法―女性OABと前立腺肥大症を伴わない男性OAB― Current Therapy 2016.34(12):1174-1179
Masaki Yoshida, Hotta S, Hiro S, Yamagami H, Yokoyama O Efficacy and Safety of Fesoterodine Treatment for Overactive Bladder (OAB) Symptoms in Elderly Women With and Without Hypertension International Continence Society 2016
Hirao Y, Torimoto K, Shinohara M, Masumori N, Takeda M, Ishizuka O, Yoshida M, Hirayama A, Takei M, Fujimoto K.A novel handheld home-uroflowmetry, P-Flowdiary® International Continence Society 2016
Castro-Diaz D, Cardoze L, Constantini E, Kocjancic E, Yoshida M, Espuna M, Cotterill N, Lemos N, Bosch R, Tarcan T ICI: Patient Assessment, ICI Committee Report International Continence Society 2016
Yoshida M, Flores NM, Vietri J, Lee M, Murakami M Burden of benign prostatic hyperplasia among men in Japan: Patient-reported outcomes among those diagnosed and experiencing symptoms.Int J Urol.2015. 22(10) 949-55
Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K.Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).BJU Int. 2015. 116(4) 612-22
Yokoyama O, Yamaguchi A, Yoshida M, Yamanishi T, Ishizuka O, Seki N, Takahashi S, Yamaguchi O, Higo N, Minami H, Masegi Y.Once-daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post-hoc analysis of a Phase III randomized clinical trial.Int J Urol. 2015. 22(7) 684-8
Nishizawa O, Yoshida M, Takeda M, Yokoyama O, Morisaki Y, Murakami M, Viktrup L.Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analyses of data pooled from three randomized, double-blind, placebo-controlled studies.Int J Urol. 2015. 22(4) 378-84
Yoshida M, Ogama N, Nakai T, Niida S, Toba K, Sakurai T Frontal white matter hyperintensity predicts lower urinary tract dysfunction in elderly with amnestic mild cognitive function and Alzheimer disease 2015 International Continence Society
Yoshida M, Otani M, Miyamoto Y, Kudo J, Yamaguchi O Development of new nomograms if urinary flow rates in Japanese men 2015 International Continence Society
Funahashi Y, Yoshida M, Yamamoto T, Matsukawa Y, Majima T, Gotoh M The Effect of Silodosin on the Prostatic Microcirculation in a Prostatitis Rat Model Induced by Urine Reflux 2015 International Continence Society
